search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CLINICAL SPOTLIGHTS


MARCH 31-APRIL 3, 2019 | GRAPEVINE, TEXAS


Proficiency testing results automated with API DataDirect!


DataDirect allows you to upload proficiency results from your LIS or Middleware to your online result forms. It’s free, saves time, and


eliminates clerical errors! Visit our booth for a demon- stration!


American Proficiency Institute Visit us at CLMA, Booth 607


New HemosIL® HIT-Ab(PF4-H) Assay from IL


Provides detection of Heparin- Induced Thrombocytopenia (HIT) antibodies, optimizing therapeutic decisions and pa- tient care. Simple to use, fast results. Fully automated, liq-


uid, ready-to-use with results in minutes. It’s available on-demand, 24/7.


Instrumentation Laboratory Prime Plus® critical care blood gas analyzer


Stat Profile Prime Plus is a compre- hensive, whole blood critical care analyzer with 20 measured tests and 32 calculated results in a sim- ple, compact, maintenance-free device. Test menu includes blood gases, electrolytes, metabolites, and co-oximetry.


Nova Biomedical Visit Randox Laboratories at CLMA


As a world leader in the in-vitro diag- nostic industry with over 35 years’ experience, our extensive product portfolio comprises completed QC solutions, diagnostic reagents and clinical chemistry analyzers.


Randox Laboratories Visit us at CLMA, Booth 221


Revolutionary ESR testing The miniSED®


is a single position,


automated ESR analyzer with pri- mary EDTA tube sampling which produces a robust quality STAT ESR result in just 17 seconds. The newest technology at best prices.


Alcor Scientific 42 APRIL 2019 MLO-ONLINE.COM


VIROTROL PLUS-R independent monitoring PLUS-R quality


of infectious disease serological testing VIROTROL®


controls monitor the perfor- mance of in vitro serological assay procedures for infec- tious disease pathogens in-


cluding HIV-1/2, hepatitis, syphilis and more. VIROTROL’s independent assessment helps increase confidence in reporting reliable test results.


Bio-Rad Laboratories Visit us at CLMA, Booth 513


First FDA-cleared assay for M. genitalium


Hologic’s first-in-category, FDA- cleared Aptima Mycoplasma genitalium assay, provides labo- ratories with a highly sensitive and specific NAAT on the Panther System to detect this sexually- transmitted infection, and enable effective treatment.


Hologic Women’s Health Visit us at CLMA, Booth 826


CAPILLARYS 3 – Next generation of CAPILLARYS


CAPILLARYS 3 TERA* provides high-resolution separation of pro- teins, hemoglobins, and HbA1c in high-volume laboratories. With 12 capillaries, CAPILLARYS 3 TERA offers our proven technology with increased efficiency and flexibility


for your lab. *Pending FDA clearance. Sebia, Inc.


Visit us at CLMA, Booth 527 Optimize your microbiology workflow


The BD Kiestra™ Work Cell Automation (WCA) system is a modular solution de- signed for labs of all sizes that enables automated specimen processing, plate incubation and digital imag- ing in a compact footprint.


BD Diagnostic Systems


The intelligent analyzer GEM®


PremierTM system with iQM®


5000 blood gas 2 assures quality


before, during and after every sample in lab and POC testing—for improved patient care. All-in-one, multi-use cartridge offers advanced simplicity.


Instrumentation Laboratory


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48